Journal History

1994 The inaugural issue was released by Mutlimed Inc. Current Oncology was published as a quarterly journal.
2005 Journal website and peer review system was launched through Open Journal Systems.
2006 Current Oncology adopted a bimonthly publication schedule.
2008 Current Oncology was indexed in PubMed and archived in PubMed Central.
Current Oncology was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics).
2011 Current Oncology received its first Impact Factor of 1.820.
2018 Current Oncology was indexed in MEDLINE—National Library of Medicine.
2020 Current Oncology received an updated Journal Impact Factor of 2.257.
Current Oncology was published by MDPI from Volume 28, Issue 1 (2021).
The Canadian Association of Psychosocial Oncology (CAPO) became affiliated to Current Oncology.
2021 Current Oncology established the following sections:
  • Surgical Oncology;
  • Thoracic Oncology;
  • Gastrointestinal Oncology;
  • Genitourinary Oncology;
  • Neuro-Oncology;
  • Head and Neck Oncology;
  • Hematology;
  • Palliative and Supportive Care;
  • Psychosocial Oncology;
  • Health Economics;
  • Medical Oncology;
  • Bone and Soft Tissue Oncology;
  • Dermato-Oncology;
  • Gynecologic Oncology;
  • Cell Therapy.
Current Oncology received an updated Journal Impact Factor of 3.677.
The Canadian Association of Medical Oncologists (CAMO)the Canadian Association of General Practitioners in Oncology (CAGPO) and the Cell Therapy Transplant Canada (CTTC) became affiliated to Current Oncology.
2022 Current Oncology established the following sections:
  • Breast Cancer;
  • Oncology Nursing;
  • Childhood, Adolescent and Young Adult Oncology.
Current Oncology adopted a monthly publication schedule.
2023 Current Oncology received its 2022 Impact Factor (2.6).
2024 The Canadian Centre for Applied Research in Cancer Control (ARCC) became affiliated to Current Oncology.


2019–2023 Editor-in-Chief: Prof. Dr. Sharlene Gill
2023–present Editor-in-Chief: Prof. Dr. Shahid Ahmed

Section Editor-in-Chief

2021–2023 Section Editor-in-Chief: Dr. Michael T. Halpern for the section on Health Economics
2021–present Section Editor-in-Chief: Dr. Stephen Yip for the section on Neuro-Oncology
Section Editor-in-Chief: Dr. Normand Blais for the section on Thoracic Oncology
Section Editor-in-Chief
: Dr. Fiona Schulte for the section on Psychosocial Oncology
Section Editor-in-Chief
: Prof. Dr. Jörg Kleeff for the section on Surgical Oncology
Section Editor-in-Chief: Dr. David Allan for the section on Cell Therapy
2022–present Section Editor-in-Chief: Prof. Dr. Tommaso Martino De Pas for the section on Bone and Soft Tissue Oncology
Section Editor-in-Chief
: Prof. Dr. Vittorio Gebbia for the section on Medical Oncology
Section Editor-in-Chief:
 Dr. Pierre Yves Marcy for the section on Head and Neck Oncology
Section Editor-in-Chief:
Prof. Dr. Gavin Stuart for the section on Gynecologic Oncology
Section Editor-in-Chief: 
Prof. Dr. Karen A. Gelmon for the section on Breast Cancer
Section Editor-in-Chief: 
Prof. Dr. Margaret Fitch for the section on Oncology Nursing
2023–present Section Editor-in-Chief: Prof. Dr. Sharlene Gill for the section on Gastrointestinal Oncology
Back to TopTop